P.P.H. Le Brun
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology
- Pharmaceutical Science top 5%
- Molecular Medicine top 5%
- Biomedical Engineering
- Co-authors
- Harry HeijermanHenderik W. FrijlinkAnne H. de BoerDaan J. TouwElsbeth M. WestermanAlexander A. VinksPaul HagedoornAlbert C. Roldaan
- Topics
- Inhalation and Respiratory Drug Delivery (14 papers)Cystic Fibrosis Research Advances (13 papers)Safe Handling of Antineoplastic Drugs (8 papers)
- Journals
- International Journal of PharmaceuticsClinical Pharmacology & TherapeuticsEuropean Journal of Pharmaceutics and Biopharmaceutics
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
P.P.H. Le Brun
28 papers receiving 718 citations
Peers
Comparison fields: 5 of 92
- Pulmonary and Respiratory Medicine 474
- Epidemiology 166
- Pharmaceutical Science 131
- Molecular Medicine 125
- Biomedical Engineering 90
Countries citing papers authored by P.P.H. Le Brun
This map shows the geographic impact of P.P.H. Le Brun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P.H. Le Brun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P.H. Le Brun more than expected).
Fields of papers citing papers by P.P.H. Le Brun
This network shows the impact of papers produced by P.P.H. Le Brun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P.H. Le Brun. The network helps show where P.P.H. Le Brun may publish in the future.
Co-authorship network of co-authors of P.P.H. Le Brun
This figure shows the co-authorship network connecting the top 25 collaborators of P.P.H. Le Brun. A scholar is included among the top collaborators of P.P.H. Le Brun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.P.H. Le Brun. P.P.H. Le Brun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 23 | |
| 3 | 1 | |
| 4 | 27 | |
| 5 | 6 | |
| 6 | 4 | |
| 7 | 6 | |
| 8 | 16 | |
| 9 | 32 | |
| 10 | 64 | |
| 11 | 73 | |
| 12 | 8 | |
| 13 | 74 | |
| 14 | 3 | |
| 15 | 44 | |
| 16 | 77 | |
| 17 | 39 | |
| 18 | 107 | |
| 19 | 20 | |
| 20 | 47 |
About P.P.H. Le Brun
P.P.H. Le Brun is a scholar working on Occupational Therapy, Medical Laboratory Technology and Microbiology, having authored 30 papers that have together received 743 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (14 papers), Cystic Fibrosis Research Advances (13 papers) and Safe Handling of Antineoplastic Drugs (8 papers). The work is most often cited by research in Molecular Medicine (125 citations), Pharmaceutical Science (131 citations) and Pulmonary and Respiratory Medicine (474 citations). P.P.H. Le Brun has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Harry Heijerman, Henderik W. Frijlink, Anne H. de Boer, Daan J. Touw, Elsbeth M. Westerman, Alexander A. Vinks, Paul Hagedoorn, Albert C. Roldaan, Harry E. Boddé and Gregor P.M. Mannes. Their work appears in journals such as International Journal of Pharmaceutics, Clinical Pharmacology & Therapeutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.